drugset / Trial / NCT02172391

Effect of Tiotropium on Airway Diameter in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT02172391

Phase 3 Completed 81 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

Trial to investigate the acute and chronic effect of tiotropium therapy on airway diameter in COPD patients as measured by inspiratory capacity (IC).

Timeline

Start
2000-11
Primary completion
2001-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Tiotropium Other / unclassified 18 ug Inhaled